FDC Limited (BOM:531599)
India · Delayed Price · Currency is INR 427.55
+23.85 (5.91%)
At close: May 27, 2026
FDC Limited Market Cap
FDC Limited has a market cap or net worth of 69.61 billion as of May 27, 2026. Its market cap has decreased by -1.16% in one year.
Market Cap
69.61B
Enterprise Value
64.54B
Revenue
22.84B
Ranking
n/a
PE Ratio
24.73
Stock Price
427.55
Market Cap Chart
Since May 30, 2002, FDC Limited's market cap has increased from 2.73B to 69.61B, an increase of 2,452.10%. That is a compound annual growth rate of 14.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 65.73B | -4.63% |
| Dec 31, 2025 | 68.92B | -15.14% |
| Dec 31, 2024 | 81.22B | 25.96% |
| Dec 29, 2023 | 64.48B | 43.15% |
| Dec 30, 2022 | 45.04B | -12.27% |
| Dec 31, 2021 | 51.34B | -8.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 155.61B |
| Viyash Scientific | 113.76B |
| CORONA Remedies | 104.05B |
| Procter & Gamble Health | 94.97B |
| Sanofi India | 73.39B |
| Novartis India | 33.62B |
| Bliss GVS Pharma | 33.60B |
| Gufic Biosciences | 32.72B |